Dubai, UAE- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology organization, is showcasing the latest innovations from its Connected Care segment at World Health Expo (WHX Dubai 2026), a leading regional exhibition. This year BD will be spotlighting innovations in healthcare from AI-enabled technologies to pharmacy automation, reinforcing its commitment to advancing digital adoption, enhancing patient safety, and equipping clinicians with intelligent tools that drive better outcomes. Taking center stage at BD’s booth (S15.B10) are its next-generation Advanced Patient Monitoring (APM) technologies, including the HemoSphere Stream™ technology and the VitaWave Plus™ Cuff, alongside the HemoSpher Alta™ monitor.
“Our participation at World Health Expo Dubai 2026 reflects BD’s unwavering commitment to accelerating innovation that supports patient care,” said Nazih Darwish, the newly appointed President for Middle East, Turkey & Africa at BD. “From our advanced patient monitoring technologies to our intelligent medication management platforms, we are empowering clinicians with connected, data-driven solutions that enhance patient safety, simplify clinical workflows, and drive better outcomes. As healthcare systems across the region continue their digital transformation, BD remains a trusted partner in shaping a more connected, efficient, and sustainable future of care.
The European Society of Anesthesiology and Intensive Care statements suggest the importance of non-invasive hemodynamic monitoring. Access accurate, continuous, non-invasive blood pressure monitoring wherever a compatible patient monitor is available with the VitaWave Plus™ System.
Also making its debut, the HemoSphere Alta™ Monitor is designed with smart and predictive parameters, this monitor is designed to help clinicians detect hemodynamic instability before it occurs – so clinicians can stay ahead of critical moments.
The goal of BD Incada™ is to unify data across compatible BD devices, delivering enterprise-wide visibility, AI-powered insights, and enhanced security features for controlled substance management.
BD’s presence at WHX Dubai 2026 also highlights how its innovation strategy is anchored in its Signature Programmes™, which address the most critical and systemic challenges facing the healthcare industry today including patient safety, workforce sustainability, and operational efficiency.
Visitors to BD’s booth at WHX Dubai 2026 are invited to engage with BD experts, experience live demonstrations of its global debut technologies, and explore how connected, intelligent solutions are transforming care delivery across the GCC and beyond. World Health Expo Dubai, formerly Arab Health, is where the world of healthcare meets to power healthcare globally. For more than 50 years, it has served as the meeting point for professionals who move industry forward, connecting the people, products, and ideas transforming care today.
WHO’S WHO
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety, and expand access to health care.
SOURCE: SUPPLIED CONTENT / IMAGE / MEDIA RELEASE
